分子对接对预测毒理学的潜力
Pietro Cozzini1, Federica Agosta2
1Molecular Modeling Lab. Food and Drug Department, University of Parma, Parma, Italy. pietro.cozzini@unipr.it.
Methods in molecular biology (Clifton, N.J.)
|September 23, 2024
概括
这项研究使用分子对接来识别潜在的内分泌干扰物,特别关注与食物接触的化学物质,这些化学物质可能会影响参与新陈代谢的过氧酶增殖器激活受体α (PPARα).
科学领域:
- 计算毒理学计算毒理学
- 药品化学 药品化学 是一个
- 分子建模分子建模
背景情况:
- 分子建模有助于药物设计和毒理学研究.
- 识别内分泌干扰剂对于公共卫生至关重要.
- 过氧体增殖器激活受体α (PPARα) 调节葡萄糖和脂质代谢.
研究的目的:
- 描述用于预测内分泌干扰物的计算工作流程.
- 在PPARα上调查食品接触化学物质对内分泌系统的潜在干扰.
主要方法:
- 使用分子对接作为计算技术.
- 评估了与PPARα目标的连接体结合模式和相互作用能量.
- 分析食品接触化学物质,包括天然和合成物质.
主要成果:
- 工作流程成功预测了潜在的内分泌干扰物.
- 确定了与PPARα相互作用的特定食品接触化学物质.
- 提供了对这些相互作用的作用机制的见解.
结论:
- 分子对接是选潜在内分泌干扰物的有效工具.
- 描述的工作流可以帮助评估与食品接触的化学品的安全性.
- 对于显示显著PPARα相互作用的化合物,需要进一步调查.
更多相关视频
00:05In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
13.9K
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
2.6K
相关概念视频
The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
